WIKI4 50 mg | 99.60%
TargetMol
WIKI4 is a potent inhibitor of Wnt/β-catenin signaling and tankyrase 2 (TNKS2).
More Information Supplier PageWIKI4
Search Results
KM11060 100 mg | 99.67%
TargetMol
KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.
More Information Supplier PageKM11060
KM11060 10 mg | 99.67%
TargetMol
KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.
More Information Supplier PageKM11060
Eptapirone 1 mg | 99.89%
TargetMol
F 11440 is a highly effective and selective 5-HT1A receptor agonist with marked antidepressant and anxiolytic potential.
More Information Supplier PageEptapirone
Eptapirone 10 mg | 99.89%
TargetMol
F 11440 is a highly effective and selective 5-HT1A receptor agonist with marked antidepressant and anxiolytic potential.
More Information Supplier PageEptapirone
BIBS 39 5 mg | Purity Not Available
TargetMol
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageBIBS 39
BIBS 39 50 mg | Purity Not Available
TargetMol
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageBIBS 39
BIBS 39 25 mg | Purity Not Available
TargetMol
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageBIBS 39
BIBS 39 10 mg | Purity Not Available
TargetMol
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageBIBS 39
Notoginsenoside R1 5 mg | 99.69%
TargetMol
Notoginsenoside R1 has been shown to exhibit antioxidant, antiapoptotic, anti-inflammatory, and immune-stimulatory properties.
More Information Supplier PageNotoginsenoside R1
